KIAA1712, a protein integral to the proper functioning of centrosomes and microtubule organization, plays a pivotal role in the progression of the cell cycle and maintenance of cell structure integrity. As a component of the centrosome, KIAA1712 is implicated in centriole duplication and cohesion, ensuring that cell division proceeds with the necessary precision and control. Its ubiquitous expression in various tissues, with notable prevalence in the testes and endometrial tissues, signifies its essential role in cellular proliferation and function. The regulation of KIAA1712 expression is not fully understood, but it is thought to be finely tuned by the cell's intricate network of signaling pathways and transcriptional mechanisms that respond to internal and external cellular environments.
Investigating the potential activators of KIAA1712 expression, a variety of chemical compounds emerge as candidates, each with mechanisms of action that might intersect with the pathways controlling KIAA1712 synthesis. For instance, microtubule-stabilizing agents such as paclitaxel could potentially upregulate KIAA1712 by enhancing the cell's demand for functional centrosomes under stabilized microtubule conditions. Conversely, microtubule-destabilizing compounds like vinblastine may stimulate KIAA1712 expression as a cellular countermeasure to maintain microtubule integrity. Compounds such as forskolin and dibutyryl-cAMP, known to increase intracellular cAMP levels, could initiate signaling cascades that enhance KIAA1712 transcription. Histone deacetylase inhibitors like trichostatin A could promote a more transcriptionally active chromatin state, potentially leading to the upsurge of KIAA1712 expression. Meanwhile, signaling molecules such as EGF and lithium chloride could trigger intracellular pathways leading to the transcriptional activation of KIAA1712. Furthermore, cell cycle inhibitors like roscovitine could indirectly prompt an increase in KIAA1712 levels as part of the cellular response to halted cell cycle progression. It's important to consider that the interplay between these compounds and KIAA1712 expression is complex and may involve multiple regulatory layers within the cell, and that the precise mechanisms by which they could act as activators are still under investigation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Taxol stabilizes microtubules, potentially leading to an upsurge in KIAA1712 expression as cells attempt to maintain centrosome integrity under altered cytoskeletal dynamics. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $230.00 $450.00 $1715.00 $2900.00 | 4 | |
Vinblastine dismantles microtubule structures, which can trigger cellular responses that upregulate proteins like KIAA1712 to reestablish normal microtubule function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Disruption of microtubule polymerization by nocodazole may stimulate a compensatory rise in KIAA1712 expression to counteract compromised microtubule dynamics. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises cAMP levels, which could lead to the activation of PKA and subsequent transcriptional events that increase KIAA1712 synthesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As an HDAC inhibitor, trichostatin A removes acetyl groups from histones, which may lead to a more accessible chromatin state and stimulate transcription of genes including KIAA1712. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid acts as a ligand for nuclear receptors, leading to a cascade of gene transcription; it could specifically induce KIAA1712 expression as part of a broader cellular differentiation program. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit GSK-3, leading to the stimulation of Wnt signaling pathways which may upregulate KIAA1712 expression as part of cellular growth and proliferation responses. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Mimicking cAMP, dibutyryl-cAMP activates PKA, which can enhance transcriptional activity leading to the increased synthesis of proteins including KIAA1712. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
As a CDK inhibitor, roscovitine halts the cell cycle, potentially inducing an upsurge in KIAA1712 expression as the cell seeks to restore normal cycle progression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin intercalates DNA, obstructing replication and transcription. This could stimulate a cellular defense mechanism that upregulates KIAA1712 to protect centrosome function. | ||||||